| Results summary | View all lists in L2L MDB | View all genes in A02B.profile.u50 |
|
Up-regulated at middle time points (6-8 hours) following treatment of mammary carcinoma cells (MCF-7) with exogenous human growth hormone enrichment: 5.74-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 202821_S_AT | LPP | C | LIM domain containing preferred translocation partner in lipoma | ||||||||||
| 206218_AT | MAGEB2 | melanoma antigen family B, 2 | |||||||||||